Logo image of BTWN

BRIDGETOWN HOLDINGS LTD-CL A (BTWN) Stock Fundamental Analysis

NASDAQ:BTWN - Nasdaq - KYG1355U1132 - Common Stock - Currency: USD

6.15  -0.26 (-4.06%)

After market: 6.3 +0.15 (+2.44%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BTWN. BTWN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BTWN have multiple concerns. BTWN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BTWN was profitable.
In the past year BTWN has reported a negative cash flow from operations.
BTWN Yearly Net Income VS EBIT VS OCF VS FCFBTWN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA 7.56%
ROE 9.44%
ROIC N/A
ROA(3y)10.03%
ROA(5y)N/A
ROE(3y)11.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTWN Yearly ROA, ROE, ROICBTWN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 5 10 15

1.3 Margins

BTWN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTWN Yearly Profit, Operating, Gross MarginsBTWN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BTWN has less shares outstanding
The debt/assets ratio for BTWN is higher compared to a year ago.
BTWN Yearly Shares OutstandingBTWN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
BTWN Yearly Total Debt VS Total AssetsBTWN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

BTWN has an Altman-Z score of 3.20. This indicates that BTWN is financially healthy and has little risk of bankruptcy at the moment.
BTWN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.2
ROIC/WACCN/A
WACCN/A
BTWN Yearly LT Debt VS Equity VS FCFBTWN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

BTWN has a Current Ratio of 0.09. This is a bad value and indicates that BTWN is not financially healthy enough and could expect problems in meeting its short term obligations.
BTWN has a Quick Ratio of 0.09. This is a bad value and indicates that BTWN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
BTWN Yearly Current Assets VS Current LiabilitesBTWN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

BTWN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.03%.
EPS 1Y (TTM)-86.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BTWN is valuated quite expensively with a Price/Earnings ratio of 61.50.
BTWN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
Industry RankSector Rank
PE 61.5
Fwd PE N/A
BTWN Price Earnings VS Forward Price EarningsBTWN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTWN Per share dataBTWN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BTWN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIDGETOWN HOLDINGS LTD-CL A

NASDAQ:BTWN (10/12/2023, 7:59:41 PM)

After market: 6.3 +0.15 (+2.44%)

6.15

-0.26 (-4.06%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2023-08-11
Earnings (Next)11-09 2023-11-09
Inst Owners1.18%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap184.32M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 61.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.1
EY1.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS4.13
TBVpS4.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.56%
ROE 9.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)10.03%
ROA(5y)N/A
ROE(3y)11.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 3.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.4%
OCF growth 3YN/A
OCF growth 5YN/A